Chronic kidney disease (CKD) and metabolic disorders are driving a major shift in clinical diagnostics—accelerating the transition toward automated, high-precision renal testing.
Valued at USD 632.36M in 2022, the global creatinine assay market is projected to reach USD 878.00M by 2029, growing at a steady 4.80% CAGR.
Key growth catalysts:
• Shift from traditional Jaffe methods to high-specificity en... moreChronic kidney disease (CKD) and metabolic disorders are driving a major shift in clinical diagnostics—accelerating the transition toward automated, high-precision renal testing.
Valued at USD 632.36M in 2022, the global creatinine assay market is projected to reach USD 878.00M by 2029, growing at a steady 4.80% CAGR.
Key growth catalysts:
• Shift from traditional Jaffe methods to high-specificity enzymatic assays
• Rising adoption of automated clinical chemistry analyzers and point-of-care (POCT) cartridges
• Escalating prevalence of diabetes, hypertension, and age-associated renal complications
• Expansion of preclinical drug toxicity screening in biopharma pipelines
How is your diagnostic or clinical research team adapting to higher demand for interference-free renal biomarkers? 🧪
Posted by Surbhi on July 14 2026 at 07:22 PM
public
Streptavidin kits — the biotin-binding protein reagent systems enabling high-affinity (Kd ~10^-15 M), versatile detection, purification, and conjugation across immunoassays, flow cytometry, micro...
In today’s highly competitive and rapidly evolving business landscape, having access to accurate and actionable market intelligence has become more important than ever. Organizations across indus...
The global non-invasive cancer diagnostics market was valued at USD 80.9 billion in 2025 and is expected to reach USD 85.8 billion in 2026. By 2033, the market is projected to expand to USD 139.1...
Posted by Mayur on September 09 2026 at 04:25 PM
public
The global companion animal diagnostics market is witnessing steady expansion as pet ownership rises, veterinary healthcare becomes more structured, and owners place greater emphasis on preventiv...
The latest report by IMARC Group, titled "United States Point of Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End User, and Region, 2026-...
